Products

Act-On

Marketing automation for your entire customer lifecycle

act-on.com Marketing / Email Marketing

Monthly visits
None yet
No traffic data yet
ARR
$16MClaimed
≈ $1.3M/mo · 2025-01-01GetLatka
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
Jeffrey Coleman
No social account linkedCo-created with Kate Johnson, Roger Rowe
Launched
Unknown
No public launch record

Traffic & revenue

Monthly visits

No traffic data yet.

Revenue evidence

Publicly disclosed & verified revenue figures, sorted by date
  • 2025-01-01$16M/yr(≈ $1.3M/mo)ClaimedGetLatka

    “Act-On Software's annual revenue was $16M in January 2025, according to geekwire.com. No later figure is on record.”

Marketing moves

Launches, search & content, referrals, promotions

No launch, search, referral, or promotion moves recorded for this product yet.

Third-party reviews & case dossiers

Acquisition breakdowns, engineer reviews & open-source metrics
GetLatka238 team membersFunding $94.4M
2026-10-30Source

Act-On Software is marketing automation software company.

Traffic sources

Traffic breakdown

No traffic channel or country breakdown data for this website yet.

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Public pricing: high, recurringRaw source text; structured plans are extracted after website capture.

Website snapshots

Indexed 2026-11-20

Key pages

Desktop & mobile archive

Website snapshots pending capture.

Questions & evidence

What is Act-On and what platforms does it support?
Act-On is catalogued under Email Marketing: Marketing automation for your entire customer lifecycle. Supported platforms: Web.
What is Act-On's publicly disclosed revenue?
GetLatka records a founder-reported figure of $16M /yr stated on 2025-01-01.Source

Related products in this category

Marketing / Email Marketing

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.